Can Octreotide and Vitamin K Be Given Together?
Yes, octreotide and vitamin K can be safely administered together—there are no documented drug-drug interactions between these medications, and vitamin K absorption is not affected by octreotide therapy.
Evidence Supporting Concurrent Use
The FDA labeling for octreotide 11 does not list vitamin K as a contraindicated medication or one requiring dose adjustment. The drug label specifically identifies medications that require caution (cyclosporine, insulin, antidiabetic drugs, digoxin, lisinopril, bromocriptine, beta-blockers, calcium channel antagonists, levonorgestrel, and drugs metabolized by cytochrome P450 with narrow therapeutic indices like quinidine), but vitamin K is notably absent from this list 2.
Direct research evidence confirms that vitamin K absorption remains unaffected by octreotide treatment. A long-term study examining octreotide's effects over 6 years specifically measured vitamin K absorption and found it was not impaired by octreotide therapy 3. This study also evaluated vitamin D absorption and fat absorption, finding all remained in normal ranges during octreotide treatment.
Important Compatibility Consideration
While the medications can be given together, avoid mixing octreotide with vitamin K in Total Parenteral Nutrition (TPN) solutions. The FDA label explicitly states that octreotide is not compatible in TPN solutions due to formation of a glycosyl octreotide conjugate that decreases drug efficacy 11. If both medications are needed in a patient receiving TPN:
- Administer octreotide separately (subcutaneously or intravenously) rather than adding it to the TPN bag
- Vitamin K can remain in the TPN formulation or be given separately as indicated
- Research confirms octreotide activity is compromised when mixed in TPN containing lipids 4
Clinical Bottom Line
There are no pharmacokinetic or pharmacodynamic interactions requiring dose adjustments or timing modifications when using these medications together. Administer each medication according to its standard dosing schedule without concern for interference. The only restriction is avoiding physical mixing in TPN solutions.